These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 19750066)
1. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Masand PS; Roca M; Turner MS; Kane JM Prim Care Companion J Clin Psychiatry; 2009; 11(4):147-54. PubMed ID: 19750066 [TBL] [Abstract][Full Text] [Related]
2. Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa. Olivares JM; Alptekin K; Azorin JM; Cañas F; Dubois V; Emsley R; Gorwood P; Haddad PM; Naber D; Papageorgiou G; Roca M; Thomas P; Martinez G; Schreiner A Patient Prefer Adherence; 2013; 7():121-32. PubMed ID: 23390361 [TBL] [Abstract][Full Text] [Related]
4. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Sun SX; Liu GG; Christensen DB; Fu AZ Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599 [TBL] [Abstract][Full Text] [Related]
6. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP; J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic alliance, a stake in schizophrenia]. Charpentier A; Goudemand M; Thomas P Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998 [TBL] [Abstract][Full Text] [Related]
8. Medication adherence in patients with schizophrenia. Phan SV Int J Psychiatry Med; 2016; 51(2):211-9. PubMed ID: 27079779 [TBL] [Abstract][Full Text] [Related]
9. Approaches to improve adherence to pharmacotherapy in patients with schizophrenia. Shuler KM Patient Prefer Adherence; 2014; 8():701-14. PubMed ID: 24868149 [TBL] [Abstract][Full Text] [Related]
10. Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey. Olivares JM; Thirunavukarasu M; Kulkarni J; Zhang HY; Zhang M; Zhang F Neuropsychiatr Dis Treat; 2013; 9():1163-70. PubMed ID: 23976858 [TBL] [Abstract][Full Text] [Related]
11. Partial compliance and patient consequences in schizophrenia: our patients can do better. Keith SJ; Kane JM J Clin Psychiatry; 2003 Nov; 64(11):1308-15. PubMed ID: 14658944 [TBL] [Abstract][Full Text] [Related]
12. Treatment adherence and insight in schizophrenia. Bitter I; Fehér L; Tényi T; Czobor P Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885 [TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
14. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Velligan DI; Sajatovic M; Hatch A; Kramata P; Docherty JP Patient Prefer Adherence; 2017; 11():449-468. PubMed ID: 28424542 [TBL] [Abstract][Full Text] [Related]
16. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Higashi K; Medic G; Littlewood KJ; Diez T; Granström O; De Hert M Ther Adv Psychopharmacol; 2013 Aug; 3(4):200-18. PubMed ID: 24167693 [TBL] [Abstract][Full Text] [Related]
17. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229 [TBL] [Abstract][Full Text] [Related]
18. Medication adherence: a review of the literature and implications for clinical practice. Julius RJ; Novitsky MA; Dubin WR J Psychiatr Pract; 2009 Jan; 15(1):34-44. PubMed ID: 19182563 [TBL] [Abstract][Full Text] [Related]
19. Interventions to Improve Medication Adherence in People with Schizophrenia: A Systematic Review. Cahaya N; Kristina SA; Widayanti AW; Green J Patient Prefer Adherence; 2022; 16():2431-2449. PubMed ID: 36072918 [TBL] [Abstract][Full Text] [Related]
20. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]